RxDoctor Payments DataLook up a doctor →

James D Olimpio

Hematology & Oncology · Lake Success, NYNPI 1730219122

Payments from drug & device makers

$6,529,396in general payments, 2019–2025

Across 1,316 payments — averaging $4961.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Beigene, Ltd.$2.4M
  • Daiichi Sankyo Inc.$624K
  • Beone Medicines Ltd.$582K
  • Eli Lilly$556K
  • Regeneron$427K
  • Merck$335K
  • plus $1.6M from 24 others
$233in research payments, 2019–2025

Across 1 payment — averaging $233.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$233

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,529,396 in reported general payments places this provider in the 95th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York

Other hematology & oncology in Lake Success

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →